Warfarin, short bowel syndrome, and intravenous lipids.
Lutomski
D M
DM
Department of Pharmacy Services, University Hospital, Cincinnati, Ohio 45267-0740, USA.
D000925:Anticoagulants / Q000627:therapeutic use*; D004351:Drug Resistance; D005217:Fat Emulsions, Intravenous / Q000009:adverse effects*; D006801:Humans; D010288:Parenteral Nutrition / Q000009:adverse effects; D012778:Short Bowel Syndrome / Q000188:drug therapy*; D014859:Warfarin / Q000627:therapeutic use*
D000925:Anticoagulants; D005217:Fat Emulsions, Intravenous; D014859:Warfarin